Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.

Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364-78. doi: 10.1098/rstb.2011.0389. Review.

2.

Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.

Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C.

Neuropharmacology. 2013 Dec;75:155-63. doi: 10.1016/j.neuropharm.2013.07.024. Epub 2013 Aug 4.

PMID:
23924692
3.

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.

Sartim AG, Guimarães FS, Joca SR.

Behav Brain Res. 2016 Apr 15;303:218-27. doi: 10.1016/j.bbr.2016.01.033. Epub 2016 Jan 20.

PMID:
26801828
4.

Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.

Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ.

Neuropharmacology. 2017 Oct;125:220-230. doi: 10.1016/j.neuropharm.2017.07.024. Epub 2017 Jul 25.

PMID:
28754373
5.

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.

Gomes FV, Resstel LB, Guimarães FS.

Psychopharmacology (Berl). 2011 Feb;213(2-3):465-73. doi: 10.1007/s00213-010-2036-z. Epub 2010 Oct 14.

PMID:
20945065
6.

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.

Fogaça MV, Reis FM, Campos AC, Guimarães FS.

Eur Neuropsychopharmacol. 2014 Mar;24(3):410-9. doi: 10.1016/j.euroneuro.2013.10.012. Epub 2013 Oct 31.

PMID:
24321837
7.

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.

Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á.

Neuropharmacology. 2016 Apr;103:16-26. doi: 10.1016/j.neuropharm.2015.12.017. Epub 2015 Dec 19.

PMID:
26711860
8.

Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.

Roser P, Vollenweider FX, Kawohl W.

World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):208-19. doi: 10.3109/15622970801908047. Review.

PMID:
20218784
9.

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences.

Marinho AL, Vila-Verde C, Fogaça MV, Guimarães FS.

Behav Brain Res. 2015 Jun 1;286:49-56. doi: 10.1016/j.bbr.2015.02.023. Epub 2015 Feb 19.

PMID:
25701682
10.

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats.

Campos AC, de Paula Soares V, Carvalho MC, Ferreira FR, Vicente MA, Brandão ML, Zuardi AW, Zangrossi H Jr, Guimarães FS.

Psychopharmacology (Berl). 2013 Mar;226(1):13-24. doi: 10.1007/s00213-012-2878-7. Epub 2012 Sep 25.

PMID:
23007604
11.

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.

Campos AC, Guimarães FS.

Psychopharmacology (Berl). 2008 Aug;199(2):223-30. doi: 10.1007/s00213-008-1168-x. Epub 2008 May 1.

PMID:
18446323
12.

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.

Gomes FV, Del Bel EA, Guimarães FS.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:43-7. doi: 10.1016/j.pnpbp.2013.06.005. Epub 2013 Jun 19.

13.

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.

Campos AC, Guimarães FS.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1517-21. doi: 10.1016/j.pnpbp.2009.08.017. Epub 2009 Sep 6.

PMID:
19735690
14.

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR.

Br J Pharmacol. 2010 Jan;159(1):122-8. doi: 10.1111/j.1476-5381.2009.00521.x. Epub 2009 Dec 4.

15.

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.

Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS.

PLoS One. 2016 Jul 14;11(7):e0158779. doi: 10.1371/journal.pone.0158779. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0162087.

16.

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.

Campos AC, Ortega Z, Palazuelos J, Fogaça MV, Aguiar DC, Díaz-Alonso J, Ortega-Gutiérrez S, Vázquez-Villa H, Moreira FA, Guzmán M, Galve-Roperh I, Guimarães FS.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1407-19. doi: 10.1017/S1461145712001502. Epub 2013 Jan 9.

PMID:
23298518
17.

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P.

Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. Review.

PMID:
29789034
18.

The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

Hahn B.

Schizophr Bull. 2018 Jan 13;44(1):46-53. doi: 10.1093/schbul/sbx105. Review.

PMID:
29083450
19.

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.

Br J Pharmacol. 2001 Oct;134(4):845-52.

20.

5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.

Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS.

Br J Pharmacol. 2009 Jan;156(1):181-8. doi: 10.1111/j.1476-5381.2008.00046.x.

Supplemental Content

Support Center